USPTO 2015–2025 USPTO PatentsView US Corporation

Peter Thomas Roth, LLC

USPTO PatentsView assignee record - 6 granted patents across 0 technology areas, recorded in grant years 2016–2016. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Peter ranks #42,310 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 0 technology areas.

#42,310
of 49,997 US assignees by volume
0th percentile
by Innovation Score (7.3/100)
1.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42310 · US Corporation #42,310 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 6 grants
  • LOWER-Q #42,310/49,997
  • PHOTO-FINISH Personal Genome…
  • CPC-UNK CPC blank
  • INNOV-LOW 7.3/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Personal Genome Diagnostics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Peter’s 7.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Peter

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Peter's Innovation Score is 7.3/100 (0th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Peter?

Each dot is one of Peter’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Peter’s own 1.0 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Peter vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent Personal Genome Diagnostics Inc. - 6, 23.5Personal Genome D…Perspectum Limited - 6, 16PerspectumPetMatrix LLC - 6, 6.83PetmatrixPeter Opsvik AS - 6, 8.5Peter Opsvik ASPezy Computing K.K. - 6, 9.17Pezy Computing K KPhacil, LLC - 6, 21.5PhacilPhantom Cyber Corporation - 6, 15.5Phantom CyberPharmaFluidics NV - 6, 15.67PharmafluidicsPeter Thomas Roth, LLC - 6, 1Peter Thomas Roth
Peter vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Peter's grants concentrate

Peter Thomas Roth, LLC is a focused PatentsView assignee: 0 CPC subclasses . By volume, Peter sits between Personal Genome Diagnostics Inc. and PharmaFluidics NV.

Who files at Peter's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Peter holds 6 patents at rank #42,376, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Peter

By rank, the assignees closest to #42,376 in granted patent volume.

Peter's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

7 0th percentile higher than 0% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Peter Thomas Roth, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 6 100.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Peter Thomas Roth, LLC's patent record in context - here's where to go next.

  • Ranked #42,310 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Peter Thomas Roth, LLC against Personal Genome Diagnostics Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 7.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.